StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30776% above fair value
$6.82+0.17 (+2.56%)

Close on Nov 18, 2026Market cap $341.32MP/E –Yield –

CapsoVision free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CapsoVision's free cash flow for the twelve months ending Jun 30, 2026 was -$27.89M. For fiscal 2025 it was -$22.95M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.95M–
FY2024Dec 31, 2024-$20.24M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.40M–
Q1 FY2026Mar 31, 2026-$6.11M–
Q4 FY2025Dec 31, 2025-$7.69M–
Q3 FY2025Sep 30, 2025-$5.68M–
Q2 FY2025Jun 30, 2025-$4.56M–
Q1 FY2025Mar 31, 2025-$5.03M–
Q4 FY2024Dec 31, 2024-$5.40M–
Q3 FY2024Sep 30, 2024-$7.06M–

More CapsoVision figures

See a number that looks wrong?